Hans-Joachim Anders Selected Research

Infections

11/2023	The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC).
1/2023	Glomerulonephritis: immunopathogenesis and immunotherapy.
1/2022	Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.
1/2022	Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials.
1/2022	Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment.
12/2021	The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum.
1/2021	A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size.
11/2020	Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps.
1/2020	Extracellular DNA-A Danger Signal Triggering Immunothrombosis.
1/2020	Podocytopathies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans-Joachim Anders Research Topics

Disease

80	Inflammation (Inflammations) 04/2024 - 02/2003
57	Lupus Nephritis 01/2024 - 03/2004
39	Glomerulonephritis 03/2024 - 05/2001
35	Necrosis 04/2024 - 09/2009
35	Kidney Diseases (Kidney Disease) 10/2023 - 01/2004
30	Chronic Renal Insufficiency 11/2023 - 02/2003
28	Fibrosis (Cirrhosis) 01/2023 - 06/2001
25	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 03/2004
24	Proteinuria 08/2023 - 05/2001
20	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 09/2009
18	Infections 11/2023 - 02/2003
13	Neoplasms (Cancer) 04/2024 - 06/2012
13	Diabetic Nephropathies (Diabetic Nephropathy) 12/2022 - 04/2007
12	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 01/2006
12	Atrophy 01/2023 - 12/2004
12	Renal Insufficiency (Renal Failure) 01/2023 - 06/2004
9	Reperfusion Injury 01/2023 - 01/2012
9	Albuminuria 01/2023 - 05/2001
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2008
8	Ischemia 10/2023 - 02/2003
8	Nephrocalcinosis 01/2021 - 01/2013
7	COVID-19 01/2023 - 01/2020
7	Virus Diseases (Viral Diseases) 01/2022 - 01/2006
7	Nephritis 12/2020 - 04/2008
6	Wounds and Injuries (Trauma) 11/2023 - 08/2013
6	Vasculitis (Vasculitides) 10/2023 - 05/2014
5	Body Weight (Weight, Body) 11/2023 - 06/2002
5	Embolism (Embolus) 10/2023 - 10/2020
5	Thrombosis (Thrombus) 02/2023 - 02/2009
5	Hereditary Nephritis (Alport Syndrome) 01/2023 - 03/2009
5	Atherosclerosis 01/2023 - 06/2011
5	Kidney Calculi (Kidney Stone) 01/2021 - 03/2017
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 05/2004
4	Hypoxia (Hypoxemia) 04/2024 - 06/2017
4	IGA Glomerulonephritis (IGA Nephropathy) 04/2024 - 04/2010
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2023 - 01/2020
4	Hypertension (High Blood Pressure) 10/2023 - 11/2020
4	Infarction (Infarctions) 01/2023 - 10/2020
4	Hyperoxaluria (Oxaluria) 01/2021 - 03/2017
4	Disease Progression 11/2015 - 11/2005
4	Immune Complex Diseases (Immune Complex Disease) 11/2011 - 08/2007
3	Thrombotic Microangiopathies 01/2023 - 10/2015
3	Diabetes Complications 01/2023 - 03/2014

Drug/Important Bio-Agent (IBA)

28	CytokinesIBA 11/2023 - 02/2003
27	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2023 - 03/2004
26	Antigen-Antibody Complex (Immune Complex)IBA 01/2020 - 05/2001
24	ChemokinesIBA 04/2023 - 05/2001
22	AutoantibodiesIBA 11/2023 - 06/2004
21	Messenger RNA (mRNA)IBA 01/2021 - 01/2002
20	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 02/2003
18	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2002
18	InflammasomesIBA 09/2023 - 01/2011
15	Chemokine ReceptorsIBA 07/2011 - 05/2001
12	OxalatesIBA 01/2021 - 03/2014
11	Antiviral Agents (Antivirals)IBA 01/2023 - 09/2009
11	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2005
11	Immunoglobulin G (IgG)IBA 01/2019 - 12/2006
10	Histones (Histone)IBA 01/2019 - 03/2010
9	AutoantigensIBA 10/2023 - 12/2009
9	CreatinineIBA 01/2023 - 06/2002
8	SodiumIBA 04/2024 - 04/2017
8	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 04/2017
8	Complement System Proteins (Complement)IBA 03/2024 - 04/2008
8	Uric Acid (Urate)IBA 06/2023 - 03/2014
7	CollagenIBA 02/2023 - 01/2002
7	LigandsIBA 01/2022 - 06/2003
7	Nucleic AcidsIBA 09/2009 - 01/2006
6	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 01/2019
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023 - 12/2018
6	Interleukin-18 (Interleukin 18)IBA 01/2023 - 01/2011
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2009
6	Calcium OxalateIBA 01/2021 - 01/2013
6	Interleukin-6 (Interleukin 6)IBA 02/2020 - 08/2007
5	InterleukinsIBA 04/2024 - 09/2009
5	Interleukin-22 (IL-22)IBA 01/2024 - 05/2014
5	belimumabIBA 11/2023 - 01/2021
5	CholesterolIBA 10/2023 - 10/2020
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 04/2012
5	SteroidsIBA 01/2023 - 09/2011
5	Phosphotransferases (Kinase)IBA 01/2023 - 12/2016
5	VaccinesIBA 01/2022 - 03/2021
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 04/2017
5	nutlin 3IBA 01/2016 - 11/2011
5	Pattern Recognition ReceptorsIBA 01/2016 - 08/2013
5	BX 471IBA 04/2005 - 01/2002
4	Monoclonal AntibodiesIBA 01/2023 - 11/2015
4	Urea (Carbamide)FDA LinkGeneric 01/2022 - 06/2002
4	ElementsIBA 01/2022 - 02/2015
4	Interferon Type IIBA 03/2021 - 05/2005
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2009
4	Etanercept (Enbrel)FDA Link 01/2021 - 08/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018 - 12/2004
4	InterferonsIBA 09/2015 - 11/2009
4	Chemokine CCL5IBA 06/2003 - 05/2001
3	GlucocorticoidsIBA 10/2023 - 01/2020
3	HMGB1 Protein (HMG1)IBA 09/2023 - 01/2022
3	Sodium-Glucose Transport ProteinsIBA 08/2023 - 04/2017
3	cathepsin SIBA 01/2023 - 02/2015

Therapy/Procedure

43	Therapeutics 04/2024 - 12/2006
5	Immunotherapy 11/2023 - 04/2016